| Price | 15.00p on 17-03-2026 at 06:00:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Buy 4,445.00 at 15.69p |
| Day's Volume: | 0 |
| Last Close: | 15.00p |
| Open: | 0.00p |
| ISIN: | GB00BMC3RJ87 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 9.00p - 28.00p |
| Market Capitalisation: | £20.71m |
| VWAP: | 0.00p |
| Shares in Issue: | 138.07m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Sareum (SAR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 4,445 | 15.69p | Ordinary |
16:11:12 - 16-Mar-26 |
| Buy* | 2,000 | 15.70p | Ordinary |
14:27:46 - 16-Mar-26 |
| Sell* | 5,561 | 14.90p | Ordinary |
13:22:14 - 16-Mar-26 |
| Buy* | 10,950 | 15.50p | Ordinary |
11:48:50 - 16-Mar-26 |
| Sell* | 226 | 14.871p | Ordinary |
11:14:02 - 16-Mar-26 |
| Buy* | 19,480 | 15.40p | Ordinary |
10:28:43 - 16-Mar-26 |
| Buy* | 25,912 | 15.40p | Ordinary |
10:05:32 - 16-Mar-26 |
| Sell* | 20,000 | 14.86p | Ordinary |
09:28:18 - 16-Mar-26 |
| Buy* | 1,052 | 15.50p | Ordinary |
08:58:07 - 16-Mar-26 |
| Sell* | 7,301 | 14.851p | Ordinary |
08:03:53 - 16-Mar-26 |
Sareum (SAR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Mar 2026 7:00 am | RNS | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 3rd Mar 2026 7:00 am | RNS | Notice of Results and Investor Presentation |
| 17th Feb 2026 7:00 am | RNS | Restart of Phase 2-enabling toxicology programme |
| 23rd Jan 2026 4:36 pm | RNS | Form 8.3 - Oxford Biomedica plc |
| 9th Dec 2025 4:25 pm | RNS | Results of AGM |
| 9th Dec 2025 7:00 am | RNS | Annual General Meeting Statement |
| 17th Nov 2025 7:00 am | RNS | Notice of AGM, Annual Report and Accounts |
| 30th Oct 2025 7:00 am | RNS | Appointment of Joint Corporate Broker |
| 23rd Oct 2025 7:00 am | RNS | Preliminary Results for Year Ended 30 June 2025 |
